Regulatory News
Wednesday, March 23, 2016
BRIEF-Biolinerx says initiation of phase 2 trial for BL-8040 as Novel Stem Cell Mobilization Treatment
March 23 (Reuters) - Biolinerx Announces Initiation Of Phase
2 Trial For Bl
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment